This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/business/520907-stock-futures-sink-covid-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Stock futures sink after US calls for pause of Johnson & Johnson Covid vaccine rollout due to health issues | Stock futures sink after US calls for pause of Johnson & Johnson Covid vaccine rollout due to health issues |
| (5 months later) | |
| US stock futures slid on Tuesday morning after US federal health officials called for a pause in the rollout of Johnson & Johnson's coronavirus vaccine amid concerns over rare blood clots. | US stock futures slid on Tuesday morning after US federal health officials called for a pause in the rollout of Johnson & Johnson's coronavirus vaccine amid concerns over rare blood clots. |
| Contracts on the Dow Jones sold off 200 points following the news. The S&P 500 futures were down 0.3% at 4,127, while Nasdaq also pivoted lower by 0.3%. A day earlier, all the three major indexes ended slightly below record levels. | Contracts on the Dow Jones sold off 200 points following the news. The S&P 500 futures were down 0.3% at 4,127, while Nasdaq also pivoted lower by 0.3%. A day earlier, all the three major indexes ended slightly below record levels. |
| Shares of Dow component Johnson & Johnson also sank almost 3% in pre-market trading on Tuesday. | Shares of Dow component Johnson & Johnson also sank almost 3% in pre-market trading on Tuesday. |
| “We are recommending a pause in the use of this vaccine out of an abundance of caution,” the US Food and Drug Administration (FDA) said in a Twitter post, pointing toward six “extremely rare” cases of people suffering a “severe type of blood clot” after being vaccinated. Over 6.8 million Americans have received the Johnson & Johnson vaccine, with even more having gotten the job internationally. | “We are recommending a pause in the use of this vaccine out of an abundance of caution,” the US Food and Drug Administration (FDA) said in a Twitter post, pointing toward six “extremely rare” cases of people suffering a “severe type of blood clot” after being vaccinated. Over 6.8 million Americans have received the Johnson & Johnson vaccine, with even more having gotten the job internationally. |
| The health agencies said they are reviewing data over six reported US cases of a severe blood clot in individuals after receiving the vaccine, and have recommended the pause "out of an abundance of caution," the FDA added. | The health agencies said they are reviewing data over six reported US cases of a severe blood clot in individuals after receiving the vaccine, and have recommended the pause "out of an abundance of caution," the FDA added. |
| Johnson & Johnson said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data. | Johnson & Johnson said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data. |
| For more stories on economy & finance visit RT's business section | For more stories on economy & finance visit RT's business section |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |